Prescribing in pregnancy: navigating risks and benefits
Pract Neurol
.
2023 Oct;23(5):366-367.
doi: 10.1136/pn-2023-003812.
Epub 2023 Jul 24.
Authors
Ruth Dobson
1
2
,
Caroline Ovadia
3
,
Joela Mathews
4
,
Peter Brex
5
Affiliations
1
Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University, London, UK ruth.dobson@qmul.ac.uk.
2
Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK.
3
Department of Women and Children's Health, King's College London, London, UK.
4
Pharmacy, Royal London Hospital, Barts Health NHS Trust, London, UK.
5
Department of Neurology, King's College Hospital NHS Foundation Trust, London, UK.
PMID:
37487704
DOI:
10.1136/pn-2023-003812
No abstract available
Keywords:
PHARMACOLOGY.
Publication types
Editorial
MeSH terms
Drug Prescriptions
Female
Humans
Pregnancy
Pregnancy Complications* / drug therapy
Risk Assessment